H.R. 3269: ETHIC Act

H.R. 3269 is a federal bill in the 119th Congress. Before this bill, pharmaceutical companies could assert numerous related patents, known as patent thickets, in a single lawsuit against generic or biosimilar drug manufacturers, potentially delaying generic drug competition. After this bill takes effect,… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.